메뉴 건너뛰기




Volumn 69, Issue 1, 2014, Pages 101-110

Evolution toward high-level fluoroquinolone resistance in Francisella species

Author keywords

Antibiotic resistance; Ciprofloxacin; DNA gyrase; Topoisomerase IV; Tularaemia; Type II topoisomerase

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CIPROFLOXACIN; DNA TOPOISOMERASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; DOXYCYCLINE; ERYTHROMYCIN; GENOMIC DNA; GENTAMICIN; LEVOFLOXACIN; MACROLIDE; MOXIFLOXACIN; QUINOLONE DERIVATIVE; TETRACYCLINE DERIVATIVE;

EID: 84890370569     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt321     Document Type: Article
Times cited : (52)

References (39)
  • 1
    • 84890398924 scopus 로고    scopus 로고
    • WHO Guidelines On Tularaemia.
    • (16 January 2010, date last accessed).
    • WHO Guidelines On Tularaemia. http://www.cdc.gov/tularemia/resources/whotularemiamanual.pdf (16 January 2010, date last accessed).
  • 2
    • 0021057783 scopus 로고
    • Subspecific taxonomy of Francisella tularensis McCoy and Chapin 1912
    • Olsufjev NG, Meshcheryakova IS. Subspecific taxonomy of Francisella tularensis McCoy and Chapin 1912. Int J Syst Bacteriol 1983; 33: 872-4.
    • (1983) Int J Syst Bacteriol , vol.33 , pp. 872-874
    • Olsufjev, N.G.1    Meshcheryakova, I.S.2
  • 3
    • 34748915252 scopus 로고    scopus 로고
    • Molecular epidemiology, evolution, and ecology of Francisella
    • Keim P, Johansson A, Wagner DM. Molecular epidemiology, evolution, and ecology of Francisella. Ann NY Acad Sci 2007; 1105: 30-66.
    • (2007) Ann NY Acad Sci , vol.1105 , pp. 30-66
    • Keim, P.1    Johansson, A.2    Wagner, D.M.3
  • 4
    • 77953278764 scopus 로고    scopus 로고
    • Simultaneous detection ofCDCcategory "A"DNA and RNA bioterrorism agents by use of multiplex PCR and RT-PCR enzyme hybridization assays
    • HeJ, Kraft AJ, FanJ et al. Simultaneous detection ofCDCcategory "A"DNA and RNA bioterrorism agents by use of multiplex PCR and RT-PCR enzyme hybridization assays. Viruses 2009; 1: 441-59.
    • (2009) Viruses , vol.1 , pp. 441-459
    • He, J.1    Kraft, A.J.2    Fan, J.3
  • 5
    • 33645222064 scopus 로고    scopus 로고
    • Bichat guidelines for the clinical management of tularemia and bioterrorism-related tularemia
    • Bossi P, Tegnell A, Baka A et al. Bichat guidelines for the clinical management of tularemia and bioterrorism-related tularemia. Euro Surveill 2004; 9: E9-10.
    • (2004) Euro Surveill , vol.9
    • Bossi, P.1    Tegnell, A.2    Baka, A.3
  • 6
    • 10844259240 scopus 로고    scopus 로고
    • Tularemia as a biological weapon: medical and public healthmanagement
    • Dennis DT, Inglesby TV, Henderson DA et al. Tularemia as a biological weapon: medical and public healthmanagement. JAMA2002; 287: 452-3.
    • (2002) JAMA , vol.287 , pp. 452-453
    • Dennis, D.T.1    Inglesby, T.V.2    Henderson, D.A.3
  • 8
    • 67651202552 scopus 로고    scopus 로고
    • Reintroduction of two virulence loci restores full virulence to the live vaccine strain of Francisella tularensis
    • Salomonsson E, Kuoppa K, Forslund AL et al. Reintroduction of two virulence loci restores full virulence to the live vaccine strain of Francisella tularensis. Infect Immun 2009; 77: 3424-31.
    • (2009) Infect Immun , vol.77 , pp. 3424-3431
    • Salomonsson, E.1    Kuoppa, K.2    Forslund, A.L.3
  • 9
  • 10
    • 34748881897 scopus 로고    scopus 로고
    • New approaches to diagnosis and therapy of tularemia
    • Tärnvik A, Chu MC. New approaches to diagnosis and therapy of tularemia. Ann NY Acad Sci 2007; 1105: 378-404.
    • (2007) Ann NY Acad Sci , vol.1105 , pp. 378-404
    • Tärnvik, A.1    Chu, M.C.2
  • 11
    • 0035882430 scopus 로고    scopus 로고
    • Tularemia epidemic in northwestern Spain: clinical description and therapeutic response
    • Perez-Castrillon JL, Bachiller-Luque P, Martin-LuqueroMet al. Tularemia epidemic in northwestern Spain: clinical description and therapeutic response. Clin Infect Dis 2001; 33: 573-6.
    • (2001) Clin Infect Dis , vol.33 , pp. 573-576
    • Perez-Castrillon, J.L.1    Bachiller-Luque, P.2    Martin-Luquero, M.3
  • 13
    • 44449141330 scopus 로고    scopus 로고
    • In vitro susceptibility of isolates of Francisella tularensis types A and B from North America
    • Urich SK, Petersen JM. In vitro susceptibility of isolates of Francisella tularensis types A and B from North America. Antimicrob Agents Chemother 2008; 52: 2276-8.
    • (2008) Antimicrob Agents Chemother , vol.52 , pp. 2276-2278
    • Urich, S.K.1    Petersen, J.M.2
  • 14
    • 67650751595 scopus 로고    scopus 로고
    • Mutational paths towards increased fluoroquinolone resistance in Legionella pneumophila
    • Almahmoud I, Kay E, Schneider D et al. Mutational paths towards increased fluoroquinolone resistance in Legionella pneumophila. J Antimicrob Chemother 2009; 64: 284-93.
    • (2009) J Antimicrob Chemother , vol.64 , pp. 284-293
    • Almahmoud, I.1    Kay, E.2    Schneider, D.3
  • 15
    • 17644405067 scopus 로고    scopus 로고
    • Mechanisms of fluoroquinolone resistance in Escherichia coli and Salmonella: recent developments
    • Hopkins KL, Davies RH, Threlfall EJ. Mechanisms of fluoroquinolone resistance in Escherichia coli and Salmonella: recent developments. Int J Antimicrob Agents 2005; 25: 358-73.
    • (2005) Int J Antimicrob Agents , vol.25 , pp. 358-373
    • Hopkins, K.L.1    Davies, R.H.2    Threlfall, E.J.3
  • 16
    • 15244356555 scopus 로고    scopus 로고
    • Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa
    • Lee JK, Lee YS, Park YK et al. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa. Int J Antimicrob Agents 2005; 25: 290-5.
    • (2005) Int J Antimicrob Agents , vol.25 , pp. 290-295
    • Lee, J.K.1    Lee, Y.S.2    Park, Y.K.3
  • 17
    • 77952237431 scopus 로고    scopus 로고
    • Identification of ciprofloxacin resistance by SimpleProbe, high resolution melt and pyrosequencing nucleic acid analysis in biothreat agents: Bacillus anthracis, Yersinia pestis and Francisella tularensis
    • Loveless BM, Yermakova A, Christensen DR et al. Identification of ciprofloxacin resistance by SimpleProbe, high resolution melt and pyrosequencing nucleic acid analysis in biothreat agents: Bacillus anthracis, Yersinia pestis and Francisella tularensis. Mol Cell Probes 2010; 24: 154-60.
    • (2010) Mol Cell Probes , vol.24 , pp. 154-160
    • Loveless, B.M.1    Yermakova, A.2    Christensen, D.R.3
  • 18
    • 43149106205 scopus 로고    scopus 로고
    • Rapid comparative genomic analysis for clinical microbiology: the Francisella tularensis paradigm
    • La Scola B, Elkarkouri K, LiWet al. Rapid comparative genomic analysis for clinical microbiology: the Francisella tularensis paradigm. Genome Res 2008; 18: 742-50.
    • (2008) Genome Res , vol.18 , pp. 742-750
    • La Scola, B.1    Elkarkouri, K.2    Li, W.3
  • 19
    • 77957881575 scopus 로고    scopus 로고
    • Phenotypic and genotypic characterization of macrolide resistance in Francisella tularensis subsp
    • Gestin B, Valade E, Thibault F et al. Phenotypic and genotypic characterization of macrolide resistance in Francisella tularensis subsp. holarctica biovar I. J Antimicrob Chemother 2010; 65: 2359-67.
    • (2010) holarctica biovar I. J Antimicrob Chemother , vol.65 , pp. 2359-2367
    • Gestin, B.1    Valade, E.2    Thibault, F.3
  • 20
    • 33646696219 scopus 로고    scopus 로고
    • Performance Standards for Antimicrobial Susceptibility testing-Nineteeth Informational Supplement M100-S19
    • Clinical and Laboratory Standards Institute. CLSI, Wayne, PA, USA
    • Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility testing-Nineteeth Informational Supplement M100-S19. CLSI, Wayne, PA, USA, 2009.
    • (2009)
  • 22
    • 0042622380 scopus 로고    scopus 로고
    • SWISS-MODEL: an automated protein homology-modeling server
    • Schwede T, Kopp J, Guex N et al. SWISS-MODEL: an automated protein homology-modeling server. Nucleic Acids Res 2003; 31: 3381-5.
    • (2003) Nucleic Acids Res , vol.31 , pp. 3381-3385
    • Schwede, T.1    Kopp, J.2    Guex, N.3
  • 23
    • 77955917935 scopus 로고    scopus 로고
    • Type IIA topoisomerase inhibitionby a new class of antibacterial agents
    • Bax BD, ChanPF, EgglestonDSet al. Type IIA topoisomerase inhibitionby a new class of antibacterial agents. Nature 2010; 466: 935-40.
    • (2010) Nature , vol.466 , pp. 935-940
    • Bax, B.D.1    Chan, P.F.2    Eggleston, D.S.3
  • 24
    • 67349272340 scopus 로고    scopus 로고
    • Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases
    • Laponogov I, Sohi MK, Veselkov DA et al. Structural insight into the quinolone-DNA cleavage complex of type IIA topoisomerases. Nat Struct Mol Biol 2009; 16: 667-9.
    • (2009) Nat Struct Mol Biol , vol.16 , pp. 667-669
    • Laponogov, I.1    Sohi, M.K.2    Veselkov, D.A.3
  • 25
    • 0035987167 scopus 로고    scopus 로고
    • In vitro susceptibility toquinolones of Francisella tularensis subsp
    • JohanssonA, Urich SK, ChuMCet al. In vitro susceptibility toquinolones of Francisella tularensis subsp. tularensis. Scand J Infect Dis 2002; 34: 327-30.
    • (2002) tularensis. Scand J Infect Dis , vol.34 , pp. 327-330
    • Johansson, A.1    Urich, S.K.2    Chu, M.C.3
  • 27
    • 21844443566 scopus 로고    scopus 로고
    • The quinolones: past, present, and future
    • Andriole VT. The quinolones: past, present, and future. Clin Infect Dis 2005; 41 Suppl 2: S113-9.
    • (2005) Clin Infect Dis , vol.41 , Issue.SUPPL. 2
    • Andriole, V.T.1
  • 28
    • 21844477302 scopus 로고    scopus 로고
    • Mechanisms of resistance to quinolones
    • Jacoby GA. Mechanisms of resistance to quinolones. Clin Infect Dis 2005; 41 Suppl 2: S120-6.
    • (2005) Clin Infect Dis , vol.41 , Issue.SUPPL. 2
    • Jacoby, G.A.1
  • 29
    • 35848954104 scopus 로고    scopus 로고
    • Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation
    • Henrichfreise B, Wiegand I, Pfister W et al. Resistance mechanisms of multiresistant Pseudomonas aeruginosa strains from Germany and correlation with hypermutation. Antimicrob Agents Chemother 2007; 51: 4062-70.
    • (2007) Antimicrob Agents Chemother , vol.51 , pp. 4062-4070
    • Henrichfreise, B.1    Wiegand, I.2    Pfister, W.3
  • 30
    • 0025930861 scopus 로고
    • Quinolone resistancedetermining region in the DNA gyrase gyrB gene of Escherichia coli
    • Yoshida H, Bogaki M, Nakamura M et al. Quinolone resistancedetermining region in the DNA gyrase gyrB gene of Escherichia coli. Antimicrob Agents Chemother 1991; 35: 1647-50.
    • (1991) Antimicrob Agents Chemother , vol.35 , pp. 1647-1650
    • Yoshida, H.1    Bogaki, M.2    Nakamura, M.3
  • 31
    • 0031407768 scopus 로고    scopus 로고
    • DNA gyrase, topoisomerase IV, and the 4-quinolones
    • Drlica K, Zhao X. DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 1997; 61: 377-92.
    • (1997) Microbiol Mol Biol Rev , vol.61 , pp. 377-392
    • Drlica, K.1    Zhao, X.2
  • 32
    • 0025758726 scopus 로고
    • heC-terminaldomainoftheEscherichiacoliDNAgyrase A subunit is a DNA-binding protein
    • ReeceJ, MaxwellA. TheC-terminaldomainoftheEscherichiacoliDNAgyrase A subunit is a DNA-binding protein. Nucleic Acids Res 1991; 19: 1399-405.
    • (1991) Nucleic Acids Res , vol.19 , pp. 1399-1405
    • Reece, J.1    Maxwell, A.T.2
  • 33
    • 11144235253 scopus 로고    scopus 로고
    • Efflux-mediated antibiotics resistance in bacteria
    • Cattoir V. Efflux-mediated antibiotics resistance in bacteria. Pathol Biol 2004; 52: 607-16.
    • (2004) Pathol Biol , vol.52 , pp. 607-616
    • Cattoir, V.1
  • 34
    • 0029890489 scopus 로고    scopus 로고
    • pHmodulation of aminoglycoside resistance in Staphylococcus epidermidis harbouring 6'-N-aminoglycoside acetyltransferase
    • Culebras E, Martínez JL, Baquero Fet al. pHmodulation of aminoglycoside resistance in Staphylococcus epidermidis harbouring 6'-N-aminoglycoside acetyltransferase. J Antimicrob Chemother 1996; 37: 881-9.
    • (1996) J Antimicrob Chemother , vol.37 , pp. 881-889
    • Culebras, E.1    Martínez, J.L.2    Baquero, F.3
  • 35
    • 38349144550 scopus 로고    scopus 로고
    • The AcrAB RND efflux systemfrom the live vaccine strain of Francisella tularensis is a multiple drug efflux system that is required for virulence in mice
    • Bina XR, Lavine CL, Miller MA et al. The AcrAB RND efflux systemfrom the live vaccine strain of Francisella tularensis is a multiple drug efflux system that is required for virulence in mice. FEMS Microbiol Lett 2008; 279: 226-33.
    • (2008) FEMS Microbiol Lett , vol.279 , pp. 226-233
    • Bina, X.R.1    Lavine, C.L.2    Miller, M.A.3
  • 36
    • 33746027387 scopus 로고    scopus 로고
    • The identification and evaluation of ATP binding cassette systems in the intracellular bacterium Francisella tularensis
    • Atkins HS, Dassa E, Walker NJ et al. The identification and evaluation of ATP binding cassette systems in the intracellular bacterium Francisella tularensis. Res Microbiol 2006; 157: 593-604.
    • (2006) Res Microbiol , vol.157 , pp. 593-604
    • Atkins, H.S.1    Dassa, E.2    Walker, N.J.3
  • 37
    • 2542583245 scopus 로고    scopus 로고
    • The fate of competing beneficial mutations in an asexual population
    • Gerrish PJ, Lenski RE. The fate of competing beneficial mutations in an asexual population. Genetica 1998; 102-103: 127-44.
    • (1998) Genetica , vol.102-103 , pp. 127-144
    • Gerrish, P.J.1    Lenski, R.E.2
  • 38
    • 0039229975 scopus 로고    scopus 로고
    • Evolution of antibiotic resistance
    • Baquero F, Blasquez J. Evolution of antibiotic resistance. Trends Ecol Evol 1997; 12: 482-7.
    • (1997) Trends Ecol Evol , vol.12 , pp. 482-487
    • Baquero, F.1    Blasquez, J.2
  • 39
    • 33645666942 scopus 로고    scopus 로고
    • Darwinian evolution can follow only very few mutational paths to fitter proteins
    • Weinreich DM, Delaney NF, DePristo MA et al. Darwinian evolution can follow only very few mutational paths to fitter proteins. Science 2006; 312: 111-4.
    • (2006) Science , vol.312 , pp. 111-114
    • Weinreich, D.M.1    Delaney, N.F.2    DePristo, M.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.